The Impact of Antihypertensive Drugs on the Number and Risk of Death, Stroke and Myocardial Infarction in the United States
25 Pages Posted: 14 May 2006 Last revised: 22 Jul 2022
Date Written: March 2006
Abstract
Estimating the value of medical innovation is a continual challenge. In this research, we quantify the impact of antihypertensive therapy on U.S. blood pressures, risk and number of heart attacks, strokes, and deaths. We also consider the potential for further improvements. We estimate the value of innovation using equations relating blood pressure to adverse outcomes from the Framingham Heart Study. Our results show that without antihypertensive therapy, 1999-2000 average blood pressure for the U.S. population age 40 plus would have been 10-13 percent higher. 86,000 excess premature deaths from cardiovascular disease (2001), and 833,000 hospital discharges for stroke and heart attacks (2002) would have occurred. Life expectancy would be 0.5 (men) and 0.4 (women) years lower. At guideline care, there would have been 89,000 fewer premature deaths (2001) and 420,000 fewer hospital discharges for stroke and heart attack (2002) than observed. Our analysis suggests that antihypertensive therapy has had a significant impact on cardiovascular health outcomes but that mortality gains would have been approximately twice as high if guideline care had been achieved for all.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
By David M. Cutler, Angus Deaton, ...
-
Understanding the Twentieth Century Decline in Chronic Conditions Among Older Men
-
The Costs and Benefits of Intensive Treatment for Cardiovascular Disease
By David M. Cutler, Mark B. Mcclellan, ...
-
The Technology of Birth: Is it Worth it?
By David M. Cutler and Ellen Meara
-
Your Money and Your Life: The Value of Health and What Affects it
-
Changes in the Age Distribution of Mortality Over the 20th Century
By David M. Cutler and Ellen Meara
-
By Marc T. Law and Sukkoo Kim
-
The Measure of Man and Older Age Mortality: Evidence from the Gould Sample
-
Understanding Mid-Life and Older Age Mortality Declines: Evidence from Union Army Veterans
-
Fiscal Shenanigans, Targeted Federal Health Care Funds, and Patient Mortality
By Katherine Baicker and Douglas Staiger